drugset / Trial / NCT00443131

Characterisation of the Immune Responses of 2 Experimental Malaria Vaccines

NCT00443131 ↗

Phase 2 Completed 36 enrolled GlaxoSmithKline
RandomizedParallel-groupTriple-blindPrevention

Summary

In this study, two experimental malaria vaccines (with adjuvants) are tested to evaluate and characterise how the vaccine exactly works on the immune system by comparing it to a control (without adjuvant). The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.

Timeline

Start
2007-03-26
Primary completion
2007-07-01
Completion
2007-07-13

Drugs

EvaluationDrugModalityDoseRoute
Subject GSK Malaria vaccine 257049 Vaccine — Intramuscular

Indications